A platelet viability assay (PVA) for the diagnosis of heparin-induced thrombocytopenia

Diagnosing heparin-induced thrombocytopenia (HIT) requires functional assays measuring platelet activation as they are highly specific and sensitive. A useful functional test for diagnosing HIT is the serotonin release assay (SRA), but this assay is technically demanding and requires a radioactive m...

Full description

Bibliographic Details
Main Authors: Nikola Ivetic, Donald M. Arnold, James W. Smith, Angela Huynh, John G. Kelton, Ishac Nazy
Format: Article
Language:English
Published: Taylor & Francis Group 2019-11-01
Series:Platelets
Subjects:
Online Access:http://dx.doi.org/10.1080/09537104.2018.1562169
_version_ 1797684230057099264
author Nikola Ivetic
Donald M. Arnold
James W. Smith
Angela Huynh
John G. Kelton
Ishac Nazy
author_facet Nikola Ivetic
Donald M. Arnold
James W. Smith
Angela Huynh
John G. Kelton
Ishac Nazy
author_sort Nikola Ivetic
collection DOAJ
description Diagnosing heparin-induced thrombocytopenia (HIT) requires functional assays measuring platelet activation as they are highly specific and sensitive. A useful functional test for diagnosing HIT is the serotonin release assay (SRA), but this assay is technically demanding and requires a radioactive marker. We describe an alternate functional HIT assay, the platelet viability assay (PVA), that overcomes the need for a radioactive marker by using a viability dye endpoint to measure platelet activation. We compared the performance characteristics of the PVA to the SRA. Serum samples from 76 patients with suspected HIT were tested in both the PVA and the SRA. The PVA uses calcein-AM as a marker of platelet viability, with decreases in fluorescence and cell size as surrogate markers for platelet activation. A significant linear correlation (Spearman correlation, r = −0.78, P < 0.0001) was observed between the PVA and SRA. Calcein-AM fluorescence decreased in a negative linear relationship with platelet activation as measured by 14C-serotonin release. The PVA detected all positive SRA samples, with an overall sensitivity of 100% and a specificity of 97% in comparison to the SRA. The measurement of platelet viability using the PVA provided similar results to the SRA when testing suspected HIT patient samples.
first_indexed 2024-03-12T00:27:34Z
format Article
id doaj.art-d8cd5751629f4215890dc11a02a5cdd6
institution Directory Open Access Journal
issn 0953-7104
1369-1635
language English
last_indexed 2024-03-12T00:27:34Z
publishDate 2019-11-01
publisher Taylor & Francis Group
record_format Article
series Platelets
spelling doaj.art-d8cd5751629f4215890dc11a02a5cdd62023-09-15T10:32:01ZengTaylor & Francis GroupPlatelets0953-71041369-16352019-11-013081017102110.1080/09537104.2018.15621691562169A platelet viability assay (PVA) for the diagnosis of heparin-induced thrombocytopeniaNikola Ivetic0Donald M. Arnold1James W. Smith2Angela Huynh3John G. Kelton4Ishac Nazy5McMaster UniversityMcMaster UniversityMcMaster UniversityMcMaster UniversityMcMaster UniversityMcMaster UniversityDiagnosing heparin-induced thrombocytopenia (HIT) requires functional assays measuring platelet activation as they are highly specific and sensitive. A useful functional test for diagnosing HIT is the serotonin release assay (SRA), but this assay is technically demanding and requires a radioactive marker. We describe an alternate functional HIT assay, the platelet viability assay (PVA), that overcomes the need for a radioactive marker by using a viability dye endpoint to measure platelet activation. We compared the performance characteristics of the PVA to the SRA. Serum samples from 76 patients with suspected HIT were tested in both the PVA and the SRA. The PVA uses calcein-AM as a marker of platelet viability, with decreases in fluorescence and cell size as surrogate markers for platelet activation. A significant linear correlation (Spearman correlation, r = −0.78, P < 0.0001) was observed between the PVA and SRA. Calcein-AM fluorescence decreased in a negative linear relationship with platelet activation as measured by 14C-serotonin release. The PVA detected all positive SRA samples, with an overall sensitivity of 100% and a specificity of 97% in comparison to the SRA. The measurement of platelet viability using the PVA provided similar results to the SRA when testing suspected HIT patient samples.http://dx.doi.org/10.1080/09537104.2018.1562169calcein-amhitplatelet viabilitysra
spellingShingle Nikola Ivetic
Donald M. Arnold
James W. Smith
Angela Huynh
John G. Kelton
Ishac Nazy
A platelet viability assay (PVA) for the diagnosis of heparin-induced thrombocytopenia
Platelets
calcein-am
hit
platelet viability
sra
title A platelet viability assay (PVA) for the diagnosis of heparin-induced thrombocytopenia
title_full A platelet viability assay (PVA) for the diagnosis of heparin-induced thrombocytopenia
title_fullStr A platelet viability assay (PVA) for the diagnosis of heparin-induced thrombocytopenia
title_full_unstemmed A platelet viability assay (PVA) for the diagnosis of heparin-induced thrombocytopenia
title_short A platelet viability assay (PVA) for the diagnosis of heparin-induced thrombocytopenia
title_sort platelet viability assay pva for the diagnosis of heparin induced thrombocytopenia
topic calcein-am
hit
platelet viability
sra
url http://dx.doi.org/10.1080/09537104.2018.1562169
work_keys_str_mv AT nikolaivetic aplateletviabilityassaypvaforthediagnosisofheparininducedthrombocytopenia
AT donaldmarnold aplateletviabilityassaypvaforthediagnosisofheparininducedthrombocytopenia
AT jameswsmith aplateletviabilityassaypvaforthediagnosisofheparininducedthrombocytopenia
AT angelahuynh aplateletviabilityassaypvaforthediagnosisofheparininducedthrombocytopenia
AT johngkelton aplateletviabilityassaypvaforthediagnosisofheparininducedthrombocytopenia
AT ishacnazy aplateletviabilityassaypvaforthediagnosisofheparininducedthrombocytopenia
AT nikolaivetic plateletviabilityassaypvaforthediagnosisofheparininducedthrombocytopenia
AT donaldmarnold plateletviabilityassaypvaforthediagnosisofheparininducedthrombocytopenia
AT jameswsmith plateletviabilityassaypvaforthediagnosisofheparininducedthrombocytopenia
AT angelahuynh plateletviabilityassaypvaforthediagnosisofheparininducedthrombocytopenia
AT johngkelton plateletviabilityassaypvaforthediagnosisofheparininducedthrombocytopenia
AT ishacnazy plateletviabilityassaypvaforthediagnosisofheparininducedthrombocytopenia